Antengene Corporation

Antengene Corporation

Antengene Corporation

Antengene is a biopharmaceutical company.
Founded
2016
Raised
$238M
Follow us
Alexa global traffic share
Latest funding Show all
$97,000,000
Venture capital (Series C) - 2020
QiMing Venture Partners Boyu Capital Fidelity Management & Research Company +1
$120,000,000
Venture capital (Series B) - 2019
Celgene QiMing Venture Partners Boyu Capital +3
Team Size
1–10
Employees
Location
Headquarters
$97,000,000 Venture capital (Series C)
FinSMEs

Antengene Closes US$97M Series C Financing

ChinaMoneyNetwork , DealStreetAsia

Fidelity Leads $97M Series C Round In Chinese Oncology Medicine Firm Antengene – China Money Network

$120,000,000 Venture capital (Series B)
AVCJ , PE HUB , AVCJ

China’s Antengene raises $120m Series B round

ChinaMoneyNetwork

Boyu Capital Leads $120M Series B Round Into Oncology Medicine Developer Antengene